Vietnam
· Delayed Price · Currency is VND OPC Pharmaceutical JSC Statistics
Total Valuation
OPC Pharmaceutical JSC has a market cap or net worth of VND 1.53 trillion. The enterprise value is 1.39 trillion.
| Market Cap | 1.53T |
| Enterprise Value | 1.39T |
Important Dates
The next estimated earnings date is Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | May 13, 2024 |
Share Statistics
OPC Pharmaceutical JSC has 64.05 million shares outstanding.
| Shares Outstanding | 64.05M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 13.94% |
| Owned by Institutions (%) | 13.40% |
| Float | 55.12M |
Valuation Ratios
The trailing PE ratio is 16.26.
| PE Ratio | 16.26 |
| Forward PE | n/a |
| PS Ratio | 1.56 |
| PB Ratio | 2.01 |
| P/FCF Ratio | 21.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.47, with an EV/FCF ratio of 19.75.
| EV / Earnings | 14.71 |
| EV / Sales | 1.41 |
| EV / EBITDA | 8.47 |
| EV / EBIT | 9.81 |
| EV / FCF | 19.75 |
Financial Position
The company has a current ratio of 2.60
| Current Ratio | 2.60 |
| Quick Ratio | 1.38 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 13.49% and return on invested capital (ROIC) is 10.57%.
| Return on Equity (ROE) | 13.49% |
| Return on Assets (ROA) | 7.56% |
| Return on Capital (ROIC) | 10.57% |
| Revenue Per Employee | 1.07B |
| Profits Per Employee | 102.39M |
| Employee Count | 926 |
| Asset Turnover | 0.85 |
| Inventory Turnover | 1.36 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.51% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +3.51% |
| 50-Day Moving Average | 23,816.00 |
| 200-Day Moving Average | 23,743.50 |
| Relative Strength Index (RSI) | 51.40 |
| Average Volume (20 Days) | 110,620 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, OPC Pharmaceutical JSC had revenue of VND 982.73 billion and earned 94.20 billion in profits. Earnings per share was 1,470.00.
| Revenue | 982.73B |
| Gross Profit | 480.26B |
| Operating Income | 139.83B |
| Pretax Income | 141.50B |
| Net Income | 94.20B |
| EBITDA | 162.25B |
| EBIT | 139.83B |
| Earnings Per Share (EPS) | 1,470.00 |
Balance Sheet
| Cash & Cash Equivalents | 208.72B |
| Total Debt | n/a |
| Net Cash | 208.72B |
| Net Cash Per Share | 3,258.59 |
| Equity (Book Value) | 825.14B |
| Book Value Per Share | 11,882.86 |
| Working Capital | 505.04B |
Cash Flow
In the last 12 months, operating cash flow was 86.17 billion and capital expenditures -16.00 billion, giving a free cash flow of 70.18 billion.
| Operating Cash Flow | 86.17B |
| Capital Expenditures | -16.00B |
| Free Cash Flow | 70.18B |
| FCF Per Share | 1,095.68 |
Margins
Gross margin is 48.87%, with operating and profit margins of 14.23% and 11.22%.
| Gross Margin | 48.87% |
| Operating Margin | 14.23% |
| Pretax Margin | 14.40% |
| Profit Margin | 11.22% |
| EBITDA Margin | 16.51% |
| EBIT Margin | 14.23% |
| FCF Margin | 7.14% |
Dividends & Yields
This stock pays an annual dividend of 1,500.00, which amounts to a dividend yield of 6.36%.
| Dividend Per Share | 1,500.00 |
| Dividend Yield | 6.36% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 1 |
| Payout Ratio | 86.91% |
| Buyback Yield | n/a |
| Shareholder Yield | 6.36% |
| Earnings Yield | 6.15% |
| FCF Yield | 4.58% |
Stock Splits
The last stock split was on July 21, 2022. It was a forward split with a ratio of 2.41.
| Last Split Date | Jul 21, 2022 |
| Split Type | Forward |
| Split Ratio | 2.41 |
Scores
OPC Pharmaceutical JSC has an Altman Z-Score of 4.74.
| Altman Z-Score | 4.74 |
| Piotroski F-Score | n/a |